DaVita Inc. (NYSE:DVA) Receives $166.33 Consensus Price Target from Brokerages

Shares of DaVita Inc. (NYSE:DVA) have been given an average rating of “Hold” by the six ratings firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $166.33.

Several research analysts have commented on the company. Cowen reaffirmed a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. StockNews.com raised DaVita from a “hold” rating to a “buy” rating in a report on Thursday, April 10th. Sanford C. Bernstein set a $184.00 price target on DaVita in a report on Friday, February 21st. Finally, Barclays boosted their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th.

Hedge Funds Weigh In On DaVita

Large investors have recently made changes to their positions in the stock. Epoch Investment Partners Inc. purchased a new stake in shares of DaVita during the 4th quarter worth approximately $55,100,000. Invesco Ltd. grew its holdings in DaVita by 20.9% in the fourth quarter. Invesco Ltd. now owns 1,589,545 shares of the company’s stock valued at $237,716,000 after purchasing an additional 275,284 shares during the last quarter. Iron Triangle Partners LP acquired a new position in shares of DaVita during the 4th quarter worth $38,946,000. Amundi grew its stake in DaVita by 116.4% in the 4th quarter. Amundi now owns 446,386 shares of the company’s stock valued at $68,726,000 after acquiring an additional 240,126 shares during the last quarter. Finally, GAMMA Investing LLC lifted its holdings in shares of DaVita by 14,695.8% in the first quarter. GAMMA Investing LLC now owns 234,809 shares of the company’s stock valued at $35,919,000 after purchasing an additional 233,222 shares in the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Price Performance

DVA stock opened at $146.11 on Wednesday. The stock has a market cap of $11.69 billion, a price-to-earnings ratio of 13.60, a PEG ratio of 1.07 and a beta of 1.04. DaVita has a fifty-two week low of $125.64 and a fifty-two week high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The business has a 50 day moving average price of $151.09 and a 200 day moving average price of $156.44.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Equities research analysts anticipate that DaVita will post 10.76 earnings per share for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.